SW
Stephen W Webster
Director

Stephen W Webster insider trades: Nabriva Therapeutics (NBRV) stock buys and sales

Director, Nabriva Therapeutics Last trade Aug 2, 2022 66 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2011
11
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

and 5 more companies

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 2, 2022NBRV↓ Sell$1K
Aug 2, 2021NBRV↓ Sell$932
May 29, 2018VKTX↑ Buy$42K
May 23, 2018NBRV↑ Buy$37K
Nov 16, 2017ONCE↓ Sell$701K
Aug 15, 2017ONCE↓ Sell$794K
Jul 31, 2017ONCE↓ Sell$166K
Jun 19, 2017ONCE↓ Sell$460K
Apr 25, 2017ONCE↓ Sell$552K
May 20, 2016ONCE↓ Sell$1.0M
Oct 7, 2015ONCE↓ Sell$977K
Feb 4, 2015ONCE↑ Buy$58K
Jun 27, 2011ADLR↑ Buy$19K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Stephen W Webster's insider trades

Stephen W Webster is a director at Nabriva Therapeutics (NBRV). Since Jun 27, 2011, Stephen has reported 4 open-market purchases worth $155K and 9 sales worth $4.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (46 filings), option exercises (10 filings), other transactions (4 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBRV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.